Serum cytokines in primary new daily persistent headache and chronic migraine: a case control study. [PDF]
Cheema S+7 more
europepmc +1 more source
BDNF gene polymorphysm RS2049046 in episodic and chronic migraine [PDF]
Yu. É. Azimova+2 more
openalex +1 more source
Abstract Objectives/Background Chronic migraine is a debilitating neurological disorder characterized by central sensitization and impaired brainstem habituation. OnabotulinumtoxinA is an established prophylactic treatment for chronic migraine, yet its effects on central trigeminal sensory processing remain incompletely understood.
Gerlinde Freimark+8 more
wiley +1 more source
Tolerability of switch from erenumab to fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, real-world, observational study. [PDF]
Amin FM+4 more
europepmc +1 more source
Ornithine in chronic migraine therapy and allodynia pattern: comparison with dopaminergic activation [PDF]
Maria Nicolodi, Maria Nicolodi
openalex +1 more source
Abstract Universal design (UD) is a design philosophy that offers effective concepts and tools to help designers develop accessible products, services, and environments. Despite the growing need for inclusive design strategies, UD is not typically integrated into design education, particularly textile design.
Kate Nartker+2 more
wiley +1 more source
Exploring the Impact of Osteopathic Manipulative Treatment on Chronic Migraine Relief: A Case Study. [PDF]
Lahlou Y, Aamir M, Shadiack V.
europepmc +1 more source
Prevalence, treatment and burden of chronic spontaneous urticaria in five European countries
This study evaluates prevalence, treatment patterns, disease profile and burden in patients with chronic spontaneous urticaria (CSU) in five European countries (EU5: France, Germany, Italy, Spain and the United Kingdom [UK]). CU, chronic urticaria; ER, emergency room; GAD, General Anxiety Disorder‐7; HRU, healthcare resource use; HRQoL, health‐related ...
Maria‐Magdalena Balp+8 more
wiley +1 more source
Real-World Safety and Efficacy of 156 U - 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study. [PDF]
Ahmed F+4 more
europepmc +1 more source